N-Power Medicine
Redwood City, California, United States · Biotechnology, Health Care, Medical
N-Power Medicine is a clinical research and drug development platform company that aims to integrate clinical research and routine care into a single workflow. Founded in 2021, it aims to boost clinical trial participation to accelerate oncology drug development. The company's platform includes The Kaleido Registry, a collection of prospective, real-time, standardized patient data designed to supp
Key facts
- Headquarters
- Redwood City, California, United States
- Employees
- 57
- Industries
- Biotechnology, Health Care, Medical
- Status
- Private
- Website
- www.npowermedicine.com
- Company page
Recent activity at N-Power Medicine
- : N-Power Medicine closes $32 million Series B financing to expand its oncology network and accelerate ProECA adoption.
- : N-Power Medicine announces acquisition of Syapse to enhance its oncology clinical research capabilities.
- : N-Power Medicine Collaborates with Merck to Expand Oncologist and Patient Access to Clinical Trials
- : N-Power Medicine raised $72 Million in a Series B funding round led by Merck Global Health Innovation Fund
N-Power Medicine funding history
| Date | Round | Amount |
|---|---|---|
| Sep 2026 | Series B | $32.0M |
| Jul 2024 | Series B | $72.0M |
Leadership
- Mark, CEO & Co-Founder
- Martin, Senior Director, Business Development
- Maria Ferrari, Chief of Staff
- Mark Lee, Chief Executive Officer
Verified email and direct lines for N-Power Medicine’s decision-makers are on Fundz. See plans
N-Power Medicine in the news
- N-Power Medicine Closes $32 Million Series B Financing to Expand Its Community Oncology Network and Accelerate ProECA Adoption - Business Wire (Sep 01, 2026)
- Merck partners with N-Power for oncology trial platform after leading series B - Fierce Biotech (Jul 01, 2024)
- Five Ways AI Is Transforming Cancer Care—and Companies That Are Making It Happen - AJMC (Nov 11, 2025)
- Merck’s AI Strategy: Analysis of Dominating Biopharmaceutical - klover.ai (Jul 17, 2025)
Companies similar to N-Power Medicine
- Abivax · Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics
- Specialised Therapeutics · Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics
- Ellipses Pharma Limited · Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics
- NuCana · Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics
- NRx Pharmaceuticals · Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics
About N-Power Medicine: questions and answers
What does N-Power Medicine do?
N-Power Medicine is a clinical research and drug development platform company that aims to integrate clinical research and routine care into a single workflow. Founded in 2021, it aims to boost clinical trial participation to accelerate oncology drug development. The company's platform includes The Kaleido Registry, a collection of prospective, real-time, standardized patient data designed to supp
Where is N-Power Medicine headquartered?
N-Power Medicine is headquartered in Redwood City, California, United States.
How many employees does N-Power Medicine have?
N-Power Medicine has about 57 employees.
Has N-Power Medicine raised funding?
Yes. Fundz has recorded 2 funding events for N-Power Medicine. The most recent, Series B of $32.0M, was in Sep 2026.
Who leads N-Power Medicine?
Mark is a CEO & Co-Founder at N-Power Medicine.
What is the latest news on N-Power Medicine?
On Sep 01, 2026, N-Power Medicine closes $32 million Series B financing to expand its oncology network and accelerate ProECA adoption.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy